Sarepta Therapeutics

Sarepta Therapeutics, Inc. (Nasdaq: SRPT) is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs (see the Products section below).

Sarepta Therapeutics, Inc.
Nasdaq: SRPT
Russell 1000 Index component
Headquarters
Cambridge 
Key people
Douglas S. Ingram
(CEO & President)
Revenue$301 Million(2018)
Websitewww.sarepta.com
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.